FDA drug approvals recorded by openFDA between 2026-09-13 and 2026-09-27, newest first. Company is the first listed manufacturer; tickers link to Seeking Alpha.
| Approval Date | Company | Drug | Ticker |
|---|---|---|---|
| 2026-09-22 | Alembic Pharmaceuticals Limited | TELMISARTAN AND AMLODIPINE | n/a |
| 2026-09-22 | Amici Pharma, Inc. | RISPERIDONE | n/a |
| 2026-09-22 | Bayer HealthCare Pharmaceuticals Inc. | NUBEQA | BAYRY |
| 2026-09-22 | Eugia US LLC | KETAMINE HYDROCHLORIDE | n/a |
| 2026-09-22 | GLENMARK PHARMACEUTICALS INC., USA | EPINEPHRINE | n/a |
| 2026-09-22 | Novartis Pharmaceuticals Corporation | SCEMBLIX | NVS |
| 2026-09-21 | Merck Sharp & Dohme LLC | WINREVAIR | MRK |
| 2026-09-18 | AMNEAL | LANREOTIDE ACETATE | AMNL |
| 2026-09-18 | BAXTER HLTHCARE CORP | ROCURONIUM BROMIDE | BAX |
| 2026-09-18 | Eli Lilly and Company | INLURIYO | LLY |
| 2026-09-18 | Eli Lilly and Company | VERZENIO | LLY |
| 2026-09-18 | HIKMA | DEFLAZACORT | n/a |
| 2026-09-18 | INTRABIO | AQNEURSA | n/a |
| 2026-09-18 | Ipsen Biopharmaceuticals, Inc. | SOHONOS | n/a |
| 2026-09-18 | Trifluent Pharma LLC | DICLOFENAC POTASSIUM | n/a |
| 2026-09-17 | Actavis Pharma, Inc. | DEXTROAMPHETAMINE SULFATE | n/a |
| 2026-09-17 | Alembic Pharmaceuticals Limited | CLONIDINE HYDROCHLORIDE | n/a |
| 2026-09-17 | APOTEX | LEVOCETIRIZINE DIHYDROCHLORIDE | n/a |
| 2026-09-17 | Apotex Corp | ICOSAPENT ETHYL | n/a |
| 2026-09-17 | AUROBINDO PHARMA LTD | CYCLOSPORINE | n/a |
| 2026-09-17 | CIPLA | CALCIUM GLUCONATE IN SODIUM CHLORIDE | n/a |
| 2026-09-17 | FRESENIUS KABI USA | DAPTOMYCIN | n/a |
| 2026-09-17 | JANSSEN PHARMS | SPRAVATO | JNJ |
| 2026-09-17 | LUPIN | AMABELZ | n/a |
| 2026-09-17 | Teva Parenteral Medicines, Inc. | PALONOSETRON HYDROCHLORIDE | TEVA |
| 2026-09-17 | Zydus Pharmaceuticals USA Inc. | LACOSAMIDE | n/a |
| 2026-09-16 | American Health Packaging | GABAPENTIN | AHR |
| 2026-09-16 | ASTRAZENECA | TRUQAP | AZN |
| 2026-09-16 | Aurobindo Pharma Limited | MELOXICAM | n/a |
| 2026-09-16 | Bayer HealthCare Pharmaceuticals Inc. | KERENDIA | BAYRY |
| 2026-09-16 | Chartwell RX, LLC | CALCITRIOL | n/a |
| 2026-09-16 | Fresenius Kabi USA, LLC | GLUCAGON | n/a |
| 2026-09-16 | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | TRANEXAMIC ACID | HRTG |
| 2026-09-16 | Macleods Pharmaceuticals Limited | OLANZAPINE | n/a |
| 2026-09-16 | Novartis Pharmaceuticals Corporation | ZORTRESS | NVS |
| 2026-09-16 | NUVATION | IBTROZI | NUVB |
| 2026-09-16 | STRIDES PHARMA | DEXTROAMPHETAMINE SULFATE | n/a |
| 2026-09-16 | U.S. Pharmaceuticals | XELJANZ | n/a |
| 2026-09-16 | U.S. Pharmaceuticals | XELJANZ XR | n/a |
| 2026-09-15 | ACTAVIS TOTOWA | LETROZOLE | n/a |
| 2026-09-15 | CHARTWELL RX | PRAMIPEXOLE DIHYDROCHLORIDE | n/a |
| 2026-09-15 | DIFGEN PHARMS | EPINEPHRINE | n/a |
| 2026-09-15 | MACLEODS PHARMS | MILNACIPRAN HYDROCHLORIDE | n/a |
| 2026-09-15 | Meitheal Pharmaceuticals Inc. | GARZULYS | n/a |
| 2026-09-15 | Meitheal Pharmaceuticals Inc. | TIGECYCLINE | n/a |
| 2026-09-15 | Mylan Pharmaceuticals Inc. | AMNESTEEM | VTRS |
| 2026-09-15 | Otsuka America Pharmaceutical, Inc. | JYNARQUE | n/a |
| 2026-09-15 | Sandoz Inc | TIGECYCLINE | SDZWF |
| 2026-09-15 | STRIDES PHARMA | MILNACIPRAN HYDROCHLORIDE | n/a |
| 2026-09-15 | SUN PHARM INDUSTRIES | DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE | n/a |
| 2026-09-15 | TEVA PHARMS | CARBAMAZEPINE | TEVA |
| 2026-09-15 | Upsher-Smith Laboratories, LLC | TESTOSTERONE | n/a |
| 2026-09-15 | ZYDUS LIFESCIENCES | TRETINOIN | n/a |
| 2026-09-14 | AJANTA PHARMA LTD | HALOPERIDOL | n/a |
| 2026-09-14 | Alembic Pharmaceuticals Inc. | ITRACONAZOLE | n/a |
| 2026-09-14 | ALVOGEN | PRIMAQUINE PHOSPHATE | n/a |
| 2026-09-14 | Amneal Pharmaceuticals LLC | ITRACONAZOLE | AMNL |
| 2026-09-14 | ASTRAZENECA | TAGRISSO | AZN |
| 2026-09-14 | AUROLIFE PHARMA LLC | BECLOMETHASONE DIPROPIONATE | n/a |
| 2026-09-14 | Cranbury Pharmaceuticals, LLC | DOXYCYCLINE HYCLATE | n/a |
| 2026-09-14 | CURIUM | BEXLUTRY | n/a |
| 2026-09-14 | GENENTECH INC | EVRYSDI | RHHBY |
| 2026-09-14 | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | COLISTIMETHATE SODIUM | HRTG |
| 2026-09-14 | Micro Labs Limited | CLOBAZAM | n/a |
| 2026-09-14 | SAGENT PHARMS INC | COLISTIMETHATE SODIUM | n/a |
| 2026-09-14 | Unichem Pharmaceuticals (USA), Inc. | PRIMAQUINE PHOSPHATE | n/a |
| 2026-09-14 | VistaPharm, LLC | METHADONE HYDROCHLORIDE | n/a |
| 2026-09-14 | Xiromed LLC | NEOSTIGMINE METHYLSULFATE | n/a |
| 2026-09-14 | ZYDUS LIFESCIENCES | LETROZOLE | n/a |
| 2026-09-14 | ZYDUS PHARMS | EPINEPHRINE | n/a |
Only the 70 most relevant rows are shown. Approved applications (originals and supplements) in this window: 73; rows shown: 70; tickers identified: 22. Known pharma subsidiaries are mapped to their US-listed parent or ADR (e.g. Janssen -> JNJ, Novartis -> NVS). Companies shown as “n/a” are mostly foreign or privately held drug makers (mostly generics) with no US-listed stock.
Data source: openFDA